AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|
16.7 C
New York
Monday, October 26, 2026

Tag: report

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes

NEW YORK, June 25, 2026 Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges...

Tag along with Jason at CISCE: How is global health care linking up in China

BEIJING, June 25, 2026 /PRNewswire/ -- This is a report from China.org.cn ...

Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia

SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing...

Select Water Solutions Announces Definitive Agreement with ISE Chemicals Corporation Providing for the Development of Commercial Iodine Production Facilities Utilizing Produced Water Infrastructure Across...

First Permian Basin Commercial Iodine Facility Targeted for Commissioning in 2027 ~3,000 Tonnes Per Year of Iodine Production Targeted by End of 2030Collaboration Represents One...

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /CNW/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /PRNewswire/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

Orrön Energy announces strategic transaction to create a leading Nordic IPP

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Cloudberry Clean Energy ASA (“Cloudberry”) to combine the Company’s Nordic renewable energy platform and organisation, excluding the Karskruv windfarm, with Cloudberry (the “Transaction”), creating a leading Nordic independent power producer (“IPP”). As consideration for the Transaction, Orrön Energy will receive 27.01 percent of the shares in the enlarged Cloudberry, becoming its largest shareholder. In addition, loan balances and accrued interest of approximately MEUR 93 as of year-end 2025 will be settled or assumed by Cloudberry, and Orrön Energy will receive MEUR 4.2 in cash. Orrön Energy will take an active role in Cloudberry’s future growth through Board representation, bringing Orrön Energy’s and the Lundin Group’s experience of value creation into the combined entity. Orrön Energy will continue to own the Karskruv windfarm and its large-scale European development business, consisting of data centres, solar and battery projects.

OMS Energy Technologies Inc. Announces Fiscal Year 2026 Financial Results

Generated Record Operating Cash Flow of $54.1 Million; Maintained Profitability 

Gates Industrial Shareholders Approve Redomiciliation

DENVER, June 25, 2026 /PRNewswire/ -- Gates Industrial Corporation plc (NYSE: GTES) (the "Company" or "Gates Industrial Corporation") today announced that its shareholders have...

BZAI Investor News: If You Have Suffered Losses in Blaize Holdings, Inc. (NASDAQ: BZAI), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Blaize Holdings, Inc. (NASDAQ: BZAI) resulting from allegations that Blaize may have issued materially misleading business information to the investing public.

MAYFAIR ANNOUNCES RESULTS OF 2026 ANNUAL GENERAL AND SPECIAL MEETING AND GRANT OF STOCK OPTIONS

TORONTO, June 25, 2026 /CNW/ - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV: MFG) (NYSE American: MINE) is pleased to announce...

MAYFAIR ANNOUNCES RESULTS OF 2026 ANNUAL GENERAL AND SPECIAL MEETING AND GRANT OF STOCK OPTIONS

TORONTO, June 25, 2026 /PRNewswire/ - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV: MFG) (NYSE American: MINE) is pleased to announce...

DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy

Newly published prospective study shows DecisionDx-Melanoma's i31-SLNB test result more accurately identifies patients at low and high risk of sentinel lymph node (SLN) positivity...

Bee Naturals Releases Report on Rising Niacinamide Concentrations in Skincare Products

FDA-registered manufacturer examines growing use of high-concentration niacinamide formulas and reports that ingredient balance may play a greater role in product performance than active percentage alone.
FDA-registered manufacturer examines growing use of high-concentration niacinamide formulas and reports that ingredient balance may play a greater role in product performance than active percentage alone.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReport